Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Prospective, Randomized, Controlled, Trial, Comparing the Safety and Efficacy of ActiGraft Pro™ to Standard of Care in Patients With Chronic Neuropathic Diabetic Foot Ulcers

NCT04185558 is registered in ClinicalTrials.gov with RedDress Ltd. as lead sponsor.

NCT NCT04185558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Prospective, Randomized, Controlled, Trial, Comparing the Safety and Efficacy of ActiGraft Pro™ to Standard of Care in Patients With Chronic Neuropathic Diabetic Foot Ulcers
Lead sponsor
RedDress Ltd.
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2019
Completion date
April 1, 2024
Enrollment
119 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ulcer, diabetic foot